Ozempic (semaglutide)

weight loss scale weigh measure tape obesity overweight

Lilly rounds out orforglipron data ahead of obesity filings

With a complete weight loss data set in hand, Lilly is eyeing regulatory filings for orforglipron and thinks approvals could start arriving next year.

Fraiser Kansteiner Sep 17, 2025 9:00am

Yellow tape measure with a variety of weight loss medication on blue background

Lilly's oral GLP-1 tied to 12% weight loss in phase 3 trial

Aug 7, 2025 6:30am

Fierce Pharma

Novo Nordisk names new CEO as it cuts sales, profit outlook

Jul 29, 2025 10:10am

Fierce Pharma

Novo's longtime CEO Lars Fruergaard Jørgensen to step down

May 16, 2025 9:41am

Lilly's oral GLP-1 delivers Ozempic-like efficacy in phase 3

Apr 17, 2025 6:45am

Obesity biotech Metsera files for a swift IPO

Jan 11, 2025 9:05am